Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Larazotide Acetate (Investigational)
Treatment for Celiac Disease
Typical Dosage: 0.5 mg three times daily
Effectiveness
60%
Safety Score
80%
Clinical Trials
10
Participants
2K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Dosage Range
0.5 mg three times daily
Time to Effect
Weeks
Treatment Duration
Long-term daily
Evidence Quality
MODERATENumber Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Confidence Score
65%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$5,000
Monitoring:$100
Side Effect Mgmt:$50
Total Annual:$5,150
Cost-Effectiveness Analysis
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$12,875
Prescription Access Economics
Larazotide Acetate (Investigational) Outcomes
for Celiac Disease
Efficacy Outcomes
Overall Effectiveness
+60%
Response Rate
+40%
Common Side Effects
Headache
+15%
Abdominal pain
+10%
Nausea
+8%
Diarrhea
+7%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov